EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 132 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $813,817 | -77.1% | 239,358 | -50.5% | 0.00% | -100.0% |
Q2 2023 | $3,554,291 | -31.9% | 483,577 | -4.1% | 0.00% | 0.0% |
Q1 2023 | $5,221,845 | -15.6% | 504,039 | -3.8% | 0.00% | 0.0% |
Q4 2022 | $6,184,660 | -38.9% | 523,680 | +8.6% | 0.00% | -50.0% |
Q3 2022 | $10,120,000 | -32.3% | 482,164 | +0.1% | 0.00% | -33.3% |
Q2 2022 | $14,953,000 | -38.2% | 481,774 | -18.2% | 0.00% | -40.0% |
Q1 2022 | $24,197,000 | -5.8% | 589,279 | -0.3% | 0.01% | 0.0% |
Q4 2021 | $25,685,000 | -13.7% | 590,887 | -0.6% | 0.01% | -16.7% |
Q3 2021 | $29,751,000 | -9.6% | 594,188 | +13.7% | 0.01% | 0.0% |
Q2 2021 | $32,911,000 | -29.9% | 522,457 | +3.4% | 0.01% | -40.0% |
Q1 2021 | $46,946,000 | +0.7% | 505,294 | -2.9% | 0.01% | 0.0% |
Q4 2020 | $46,610,000 | -16.2% | 520,216 | -3.4% | 0.01% | -28.6% |
Q3 2020 | $55,637,000 | +30.4% | 538,430 | -0.2% | 0.01% | +27.3% |
Q2 2020 | $42,679,000 | +39.3% | 539,688 | +1.9% | 0.01% | +10.0% |
Q1 2020 | $30,640,000 | +2.6% | 529,542 | -4.4% | 0.01% | +25.0% |
Q4 2019 | $29,870,000 | -2.0% | 553,691 | -5.1% | 0.01% | 0.0% |
Q3 2019 | $30,487,000 | +3.9% | 583,149 | -4.0% | 0.01% | 0.0% |
Q2 2019 | $29,349,000 | -25.2% | 607,502 | -21.8% | 0.01% | -27.3% |
Q1 2019 | $39,253,000 | -17.0% | 776,991 | -2.6% | 0.01% | -26.7% |
Q4 2018 | $47,279,000 | -15.7% | 797,594 | -6.4% | 0.02% | +7.1% |
Q3 2018 | $56,077,000 | +46.9% | 851,840 | +12.7% | 0.01% | +40.0% |
Q2 2018 | $38,167,000 | -1.9% | 755,948 | +2.3% | 0.01% | -9.1% |
Q1 2018 | $38,915,000 | +46.0% | 739,147 | +28.9% | 0.01% | +57.1% |
Q4 2017 | $26,648,000 | +18.8% | 573,450 | +3.4% | 0.01% | +16.7% |
Q3 2017 | $22,422,000 | +16.7% | 554,345 | -2.1% | 0.01% | +20.0% |
Q2 2017 | $19,210,000 | +18.7% | 566,478 | +1.6% | 0.01% | +25.0% |
Q1 2017 | $16,184,000 | -30.9% | 557,297 | -21.8% | 0.00% | -42.9% |
Q4 2016 | $23,413,000 | +8.4% | 712,928 | +4.0% | 0.01% | +16.7% |
Q3 2016 | $21,604,000 | +14.6% | 685,194 | +2.2% | 0.01% | 0.0% |
Q2 2016 | $18,849,000 | -61.7% | 670,318 | -50.5% | 0.01% | -60.0% |
Q1 2016 | $49,182,000 | -33.8% | 1,353,022 | -27.2% | 0.02% | -31.8% |
Q4 2015 | $74,328,000 | +10.0% | 1,857,734 | -21.7% | 0.02% | +4.8% |
Q3 2015 | $67,580,000 | -25.9% | 2,372,022 | -14.3% | 0.02% | -16.0% |
Q2 2015 | $91,227,000 | +8.3% | 2,768,652 | -5.5% | 0.02% | +13.6% |
Q1 2015 | $84,237,000 | +6.5% | 2,928,950 | +0.8% | 0.02% | +4.8% |
Q4 2014 | $79,112,000 | +11.1% | 2,905,332 | -13.0% | 0.02% | +10.5% |
Q3 2014 | $71,180,000 | -53.2% | 3,340,263 | -50.7% | 0.02% | -5.0% |
Q2 2014 | $152,072,000 | +78.9% | 6,770,792 | +101.3% | 0.02% | -13.0% |
Q1 2014 | $84,982,000 | +16.2% | 3,362,908 | +5.7% | 0.02% | +15.0% |
Q4 2013 | $73,136,000 | -42.2% | 3,181,248 | -52.1% | 0.02% | +5.3% |
Q3 2013 | $126,500,000 | +156.5% | 6,640,394 | +94.1% | 0.02% | +18.8% |
Q2 2013 | $49,322,000 | – | 3,420,502 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIMZ Investment Advisors, LLC | 52,590 | $621 | 0.29% |
Values First Advisors, Inc. | 33,942 | $400,858 | 0.28% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 91,000 | $1,075,000 | 0.23% |
SummerHaven Investment Management, LLC | 25,347 | $299,348 | 0.18% |
PALISADE CAPITAL MANAGEMENT, LP | 501,672 | $5,924,746 | 0.16% |
CORNERCAP INVESTMENT COUNSEL INC | 67,457 | $796,667 | 0.14% |
Edgestream Partners, L.P. | 94,553 | $1,116,671 | 0.13% |
OCCUDO QUANTITATIVE STRATEGIES LP | 86,569 | $1,022,380 | 0.12% |
DUALITY ADVISERS, LP | 77,298 | $912,889 | 0.10% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,253,042 | $14,798,427 | 0.10% |